$TXG

10x Genomics, Inc.

Nasdaq · Technology · Laboratory Analytical Instruments · Pleasanton, CA

TXG chart

What traders are saying about $TXG

Latest posts

10x Genomics, Inc. news

10x Genomics, Inc. key financials

USD2025202420232022
Revenue$642.8M$610.8M$618.7M$516.4M
Net income-$43.5M-$182.6M-$255.1M-$166.0M
Diluted EPS$-0.35$-1.52$-2.18$-1.46
Total assets (year end)$1.04B$918.6M$965.1M$1.03B
Cash and equivalents (year end)–$344.1M$359.3M$219.7M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About 10x Genomics, Inc.

Ticker
TXG (Nasdaq)
Industry
Laboratory Analytical Instruments
Headquarters
Pleasanton, CA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1770787

Frequently asked questions

What exchange is 10x Genomics, Inc. listed on?

10x Genomics, Inc. trades on the Nasdaq under the ticker symbol TXG.

What industry is 10x Genomics, Inc. in?

10x Genomics, Inc. is classified by the SEC under "Laboratory Analytical Instruments", part of the Technology sector on StockTweeting.

Where is 10x Genomics, Inc. headquartered?

10x Genomics, Inc.'s business address on file with the SEC is in Pleasanton, CA.

When does 10x Genomics, Inc.'s fiscal year end?

10x Genomics, Inc.'s fiscal year ends on December 31.

How much revenue did 10x Genomics, Inc. report?

10x Genomics, Inc. reported $642.8M in revenue for calendar year 2025, according to its SEC filings.